Skip to content
Certara Drug Interaction Solutions
  • About Us
    • What we do
    • How we work
    • Our team
    • History
    • Linked
  • Our Solutions
    • DIDB® – The Drug Interaction Database
    •   Human in vitro datasets
    •   Clinical datasets
    • Custom solutions
    • Testimonials
  • Subscription
    • Licensing
    • Account policies
  • News
  • Support
  • Contact Us
  • Sign in
  • DIDB

Privacy statement

Now that Drug Interaction Solutions is part of Certara, please see the Certara Privacy Notice for our new policy.

Need more information, please contact us.

Follow us on Linked

Brochures

  • Why us?

News Categories

  • Events
  • New features
  • News
  • Posters
  • Publications

Recent News

  • Data Curation and Entry in DIDB – August Summary
  • Understanding the role of CYP3A in the metabolism of kinase inhibitors marketed in the past decade to better manage the risk of clinical drug-drug interactions.
  • Risk of pharmacokinetic drug-drug interactions with novel drugs approved by the US FDA in 2022: a detailed review of DDI data from NDA documentation.
  • Certara Drug Interaction Solutions team members to attend the 25th North American ISSX Meeting in Boston
  • Data Curation and Entry in DIDB – July Summary
  • Blog
  • Contact
  • Privacy
Copyright © 2023 Certara, USA. All Rights Reserved.